Zinc supplementation in neonatal respiratory distress syndrome: is it beneficial?

Zinc supplementation in neonatal respiratory distress syndrome: randomized control trial

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200919002

Enrollment

Unknown

Registered

2020-09-19

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal respiratory distress neonate &#44

Interventions

zinc is a trace element that was given to the jaundiced neonate&#44

In the intervention group&#44

100 preterm neonates with jaundice received zinc as 0.7 cm of zinc origin/kg/day orally through oro/nasogastric tube divided into 2 doses(/12 hours) which is equal 1.4 mg elemental zinc/kg/day orally

Experimental Drug,Experimental Other

Zinc supplementation,placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: neonates suffering from RDS

Exclusion criteria

Exclusion criteria: neonatal infections

Design outcomes

Primary

Measure	Time frame
respiratory distress at 5 days after end of the intervention(zinc administration) ELISA method for measuring IL-8 in neonate with respiratory distress	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Egypt

Contacts

Public Contactmohamed elfarargy

Tanta University Hospital

farargy2009@hotmail.com+201005171750

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026